Answers are grounded in this paper and cite their sources.
Background and aim: Vitamin D deficiency is a widespread public health issue, yet data regarding its prevalence and biological correlates in North African women with hormone receptor-positive (HR+) breast cancer remain limited.This study aimed to assess serum 25-hydroxyvitamin D (25{OH}D) levels and evaluate their associations with clinicopathological features in women diagnosed with HR+ breast cancer in Marrakech, Morocco.Methods: A cross-sectional study was conducted on 67 consecutive HR+ breast cancer patients treated at the Oncology Center of the Mohammed VI University Hospital in Marrakech between 2024 and 2025.Serum 25(OH)D concentrations were measured, and parametric (Pearson's r) and non-parametric (Spearman's ρ) correlation analyses were performed against clinicobiological variables.Results: Hypovitaminosis D (<30 ng/mL) was present in 100% of the cohort (mean serum level: 12.26±9.4ng/mL).Severe deficiency (<10 ng/mL) was detected in 47% (n=31), insufficiency (10-20 ng/mL) in 47% (n=32), and borderline insufficiency (20-30 ng/mL) in 6% (n=4).No patient had optimal levels (≥30 ng/mL).Serum 25(OH)D concentrations correlated positively with progesterone receptor (PR) expression (r = +0.616,p=0.005) and the Ki-67 index (ρ = +0.699,p=0.001), while demonstrating a significant inverse correlation with metastatic stage (M1 versus M0; ρ = -0.472,p=0.041).Conclusion: Hypovitaminosis D is universal and severe among HR+ breast cancer patients in Marrakech, Morocco.Lower vitamin D status is associated with metastatic disease.These findings underscore an urgent need for systematic vitamin D screening and prospective interventional trials in this population.
No takes yet. Share an insight, caveat, or question.
Haou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: